|
Shield Diagnostics' former building at Dundee Technology Park is set to be acquired by Upstate, the US biotechnology company. 16-Jun-1999 Shield Diagnostics has reached agreement with Gemini Holdings of Cambridge to develop a DNA test for osteoporosis. 20-Apr-1999 Shield Diagnostics is seeking to raise £12m in a rights issue in order to fund the proposed merger with Axis Biochemicals of Norway. 18-Mar-1999 Shield Diagnostics has secured rights from the University of Nijmegen for a new diagnostic test for rheumatoid arthritis. 11-Mar-1999 Shield Diagnostics is planning to acquire Axis Biochemicals of Norway for £67m, which will enable the two companies to jointly develop tests for assessing the risk of heart disease. 19-Jan-1999 Shield Diagnostics has opened its new headquarters in Dundee, where it will employ 115 staff. 01-Oct-1998 Shield Diagnostics has won US regulatory approval to market its AFECTA test for the risk of cardiovascular disease. 02-Sep-1998 Shield Diagnostics has announced a licensing agreement with Abbott Laboratories of the US which will involve Abbott using Shield's heart disease predictor test. 24-Jan-1998 Shield Diagnostics has won a licence to develop a test for thrombosis that uses technology developed at the University of Glasgow. 20-May-1997
|